Immuno-Oncology

Latest News

Blue and green pills © Grycaj -adobestock.com
Antibiotic Treatment Within a Year of ICI Therapy May Result in Worse Survival Outcomes

March 21st 2023

A retrospective cohort demonstrated that patients who are treated with antibiotics within 1 year before immune checkpoint inhibitor therapy may experience worse overall survival.

Bladder Cancer
CheckMate 274 Follow-Up Supports the Use of Adjuvant Immunotherapy in Bladder Cancer

March 17th 2023

kidney cancer
Nivolumab/Cabozantinib Shows Continued Benefit In Frontline Treatment of RCC

February 28th 2023

Bladder Cancer
Atezolizumab Does Not Demonstrate Significant OS Benefit Over Chemotherapy in Untreated Locally Advanced or Metastatic Urothelial Cancer

February 26th 2023

Lenvatinib/Pembrolizumab Efficacy Data Holds Up in Updated KEYNOTE-146 Analysis for Advanced Endometrial Carcinoma
Lenvatinib/Pembrolizumab Efficacy Data Holds Up in Updated KEYNOTE-146 Analysis for Advanced Endometrial Carcinoma

February 20th 2023

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.